LIUDMYLA INGLE: Open Payments
NPI 1467047266 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 8 payments from 7 companies in 2025. Trend: 2023 $691 · 2024 $906 · 2025 $236
Food & beverage: $221Education: $15
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $113 |
| Caris MPI, Inc. | 2 | $29 |
| Celgene Corporation | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| SOBI, INC | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
Products named: WAYRILZ, MI CANCER SEEK, REBLOZYL, JEMPERLI, Vonjo, VECTIBIX, FOTIVDA.
Industry payments across TX — which companies pay providers there.
